157 related articles for article (PubMed ID: 16686598)
1. MT1-MMP hemopexin domain exchange with MT4-MMP blocks enzyme maturation and trafficking to the plasma membrane in MCF7 cells.
Atkinson SJ; Roghi C; Murphy G
Biochem J; 2006 Aug; 398(1):15-22. PubMed ID: 16686598
[TBL] [Abstract][Full Text] [Related]
2. The hemopexin domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) Is not required for its activation of proMMP2 on cell surface but is essential for MT1-MMP-mediated invasion in three-dimensional type I collagen.
Wang P; Nie J; Pei D
J Biol Chem; 2004 Dec; 279(49):51148-55. PubMed ID: 15381707
[TBL] [Abstract][Full Text] [Related]
3. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
Itoh Y; Takamura A; Ito N; Maru Y; Sato H; Suenaga N; Aoki T; Seiki M
EMBO J; 2001 Sep; 20(17):4782-93. PubMed ID: 11532942
[TBL] [Abstract][Full Text] [Related]
4. Collagen binding properties of the membrane type-1 matrix metalloproteinase (MT1-MMP) hemopexin C domain. The ectodomain of the 44-kDa autocatalytic product of MT1-MMP inhibits cell invasion by disrupting native type I collagen cleavage.
Tam EM; Wu YI; Butler GS; Stack MS; Overall CM
J Biol Chem; 2002 Oct; 277(41):39005-14. PubMed ID: 12145314
[TBL] [Abstract][Full Text] [Related]
5. Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts.
Li H; Bauzon DE; Xu X; Tschesche H; Cao J; Sang QA
Mol Carcinog; 1998 Jun; 22(2):84-94. PubMed ID: 9655252
[TBL] [Abstract][Full Text] [Related]
6. The propeptide domain of membrane type 1 matrix metalloproteinase is required for binding of tissue inhibitor of metalloproteinases and for activation of pro-gelatinase A.
Cao J; Drews M; Lee HM; Conner C; Bahou WF; Zucker S
J Biol Chem; 1998 Dec; 273(52):34745-52. PubMed ID: 9856998
[TBL] [Abstract][Full Text] [Related]
7. Tracking the Cartoon mouse phenotype: Hemopexin domain-dependent regulation of MT1-MMP pericellular collagenolytic activity.
Sakr M; Li XY; Sabeh F; Feinberg TY; Tesmer JJG; Tang Y; Weiss SJ
J Biol Chem; 2018 May; 293(21):8113-8127. PubMed ID: 29643184
[TBL] [Abstract][Full Text] [Related]
8. Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation.
Overall CM; Tam E; McQuibban GA; Morrison C; Wallon UM; Bigg HF; King AE; Roberts CR
J Biol Chem; 2000 Dec; 275(50):39497-506. PubMed ID: 10991943
[TBL] [Abstract][Full Text] [Related]
9. Oligomerization through hemopexin and cytoplasmic domains regulates the activity and turnover of membrane-type 1 matrix metalloproteinase.
Lehti K; Lohi J; Juntunen MM; Pei D; Keski-Oja J
J Biol Chem; 2002 Mar; 277(10):8440-8. PubMed ID: 11779859
[TBL] [Abstract][Full Text] [Related]
10. Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase.
Kolkenbrock H; Essers L; Ulbrich N; Will H
Biol Chem; 1999 Sep; 380(9):1103-8. PubMed ID: 10543448
[TBL] [Abstract][Full Text] [Related]
11. Catalytic activities and substrate specificity of the human membrane type 4 matrix metalloproteinase catalytic domain.
Wang Y; Johnson AR; Ye QZ; Dyer RD
J Biol Chem; 1999 Nov; 274(46):33043-9. PubMed ID: 10551873
[TBL] [Abstract][Full Text] [Related]
12. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.
Will H; Atkinson SJ; Butler GS; Smith B; Murphy G
J Biol Chem; 1996 Jul; 271(29):17119-23. PubMed ID: 8663332
[TBL] [Abstract][Full Text] [Related]
13. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
14. CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain.
Mori H; Tomari T; Koshikawa N; Kajita M; Itoh Y; Sato H; Tojo H; Yana I; Seiki M
EMBO J; 2002 Aug; 21(15):3949-59. PubMed ID: 12145196
[TBL] [Abstract][Full Text] [Related]
15. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
Lehti K; Lohi J; Valtanen H; Keski-Oja J
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492
[TBL] [Abstract][Full Text] [Related]
16. Distinct roles for the catalytic and hemopexin domains of membrane type 1-matrix metalloproteinase in substrate degradation and cell migration.
Cao J; Kozarekar P; Pavlaki M; Chiarelli C; Bahou WF; Zucker S
J Biol Chem; 2004 Apr; 279(14):14129-39. PubMed ID: 14729674
[TBL] [Abstract][Full Text] [Related]
17. The tetraspanin network modulates MT1-MMP cell surface trafficking.
Schröder HM; Hoffmann SC; Hecker M; Korff T; Ludwig T
Int J Biochem Cell Biol; 2013 Jun; 45(6):1133-44. PubMed ID: 23500527
[TBL] [Abstract][Full Text] [Related]
18. Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase.
Itoh Y; Kajita M; Kinoh H; Mori H; Okada A; Seiki M
J Biol Chem; 1999 Nov; 274(48):34260-6. PubMed ID: 10567400
[TBL] [Abstract][Full Text] [Related]
19. CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase.
Suenaga N; Mori H; Itoh Y; Seiki M
Oncogene; 2005 Jan; 24(5):859-68. PubMed ID: 15558018
[TBL] [Abstract][Full Text] [Related]
20. Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2.
English WR; Puente XS; Freije JM; Knauper V; Amour A; Merryweather A; Lopez-Otin C; Murphy G
J Biol Chem; 2000 May; 275(19):14046-55. PubMed ID: 10799478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
